Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers of Irritant-Induced and Allergic Asthma
NCT02740543Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Dec 2013
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of fluticasone propionate in allergic asthma (3 arms), sponsored by NYU Langone Health. Primary endpoint: Change in Thymic Stromal Lymphopoietin (TSLP) Gene Expression at 2 weeks. Started Dec 2013; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT02740543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740543.